We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Create "Assassin" Cells Armed With Anticancer Drugs

News   May 14, 2020 | Original story from POSTECH

 
Researchers Create "Assassin" Cells Armed With Anticancer Drugs

Schematic illustration of the reinforced natural killer cell (ReNK) system and its anti?cancer effect upon encountering cancer cells. NK cells reinforced with doxorubicin (DOX)?loaded, acid?responsive micelles, home onto the tumor site. When an NK cell engages a cancer cell, an immunological synapse is formed, and acidic granules are released by the former into the synapse. Acidification of the synapse induces the release of DOX from the micelles and its diffusion into the tumor site. Credit: Won Jong Kim (POSTECH)

 
 
Advertisement
 

RELATED ARTICLES

Immune Defense Guidance System Revealed

News

A new study shows that at the beginning of an immune response, sphingosine 1 phosphate (S1P), a molecule known to mobilize immune cells into the bloodstream, rapidly shifts position into the lymph nodes.

READ MORE

Mother's Microbiota "Educates" Their Offspring's Immune System

News

New research on the development of the immune system during infancy has shown that there is a causal relationship between neonatal antibody production and the mother's microbiota.

READ MORE

New Study Explores Association Between SARS-CoV-2 and Blood Group A

News

A new study by researchers at Brigham and Women's Hospital adds to the body of work exploring blood group and COVID-19 susceptibility and severity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE